Nitrogen dioxide increases the risk of disease progression in idiopathic pulmonary fibrosis
Respirology · 2023-03 · 28 (3) · 254-261
DOI: 10.1111/resp.14373 ↗Kurz gefasst
Fachartikel in der Zeitschrift Respirology, online erschienen am 19.09.2022. Verfasst von Hee-Young Yoon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy and Respiratory Diseases, Soonchunhyang University Seoul Hospital, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Air Pollutants, Air Pollution, Idiopathic Pulmonary Fibrosis. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Korea National Institute of Health, National Research Foundation of Korea.
Abstract (Originalsprache)
Background and Objective Air pollution affects clinical course and prognosis of idiopathic pulmonary fibrosis (IPF). However, the effect of individual exposure to air pollutants on disease progression is unclear. We aimed to identify the effect of individual exposure to nitrogen dioxide (NO 2 ) and particulate matter (aerodynamic diameter ≤ 10 μm [PM 10 ]) on disease progression in patients with IPF.
Methods
The serial lung function data of 946 IPF patients (mean age: 65.4 years, male: 80.9%) were analysed. Individual‐level long‐term exposures to NO 2 and PM 10 at the residential addresses of patients were estimated using a national‐scale exposure prediction model, constructed based on air quality regulatory monitoring data. Progression was defined as a relative decline (≥10%) in forced vital capacity. Individual‐ and area‐level covariates were adjusted in the primary analysis model.
Results
Overall, 547 patients (57.8%) experienced progression during a median follow‐up of 1.0 year (interquartile range: 0.4–2.6 years). In the primary model, a 10‐ppb increase in NO 2 concentration was associated with a 10.5% increase in the risk of progression (hazard ratio [HR] = 1.105; 95% CI = 1.000–1.219) in patients with IPF. There was also an increasing trend of progression in patients with IPF according to the second to fourth quartiles of NO 2 (Q2 [HR = 1.299; 95% CI = 0.972–1.735], Q3 [1.409; 1.001–1.984], Q4 [1.598; 1.106–2.310]) compared to the first quartile. We found no association between PM 10 and progression in IPF patients.
Conclusion
Our data suggest that increased individual exposure to NO 2 can increase the risk of progression in patients with IPF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Allergy and Respiratory Diseases, Soonchunhyang University Seoul Hospital, Seoul, Republic of Korea.
- Department of Cancer Control and Population Health, Graduate School of Cancer Science and Policy, National Cancer Center, Gyeonggi, Republic of Korea.
- Environmental Health Research Division, Environmental Health Research Department, National Institute of Environmental Research, Incheon, Republic of Korea.
- Department of Pulmonary and Critical Care Medicine Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
ORCID-Profile: Hee-Young Yoon, Jin Woo Song
Förderung
- Korea National Institute of Health
- National Research Foundation of Korea
Zitieren
APA
Yoon, H. Y., Kim, S. Y., Kim, O. J., & Song, J. W. (2023). Nitrogen dioxide increases the risk of disease progression in idiopathic pulmonary fibrosis. Respirology, 28(3), 254-261. https://doi.org/10.1111/resp.14373
Vancouver
Yoon HY, Kim SY, Kim OJ, Song JW. Nitrogen dioxide increases the risk of disease progression in idiopathic pulmonary fibrosis. Respirology. 2023;28(3):254-261. doi:10.1111/resp.14373
BibTeX
@article{Yoon2023,
author = {Yoon, Hee-Young and Kim, Sun-Young and Kim, Ok-Jin and Song, Jin Woo},
title = {Nitrogen dioxide increases the risk of disease progression in idiopathic pulmonary fibrosis},
journal = {Respirology},
year = {2023},
volume = {28},
number = {3},
pages = {254--261},
doi = {10.1111/resp.14373}
}
EUVIMED